Cyclosporine | Market Exclusivity | US | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Cyclosporine
US Exclusivities

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Fisha Cyclosporine

Contact Supplier

xyz-pharma-m-2025-03-24

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

Gentec Pharmaceutical Group is focused on manufacturing & developing APIs/HPAPIs, Advanced Intermediates & Fine Chemicals.

Contact Supplier

xyz-pharma-m-2025-03-17

Contact Supplier

Cyclosporine

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

37 API Suppliers, 23 USDMF, 11 CEP/COS, 9 JDMF, 1 EU WC, 12 KDMF, 22 NDC API, 1 VMF, 14 Listed Suppliers, $ API Reference Price

37 API Suppliers
23 USDMF
11 CEP/COS
9 JDMF
1 EU WC
12 KDMF
22 NDC API
1 VMF
14 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

34 Drugs in Development

34 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

317 FDF Dossiers, 53 FDA Orange Book, 159 Europe, 20 Canada, 60 Australia, 7 South Africa, 18 Listed Dossiers

317 FDF Dossiers
53 FDA Orange Book
159 Europe
20 Canada
60 Australia
7 South Africa
18 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 100MG, CAPSULE;ORAL - 25MG, CAPSULE;ORAL - 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - 100MG
CAPSULE;ORAL - 25MG
CAPSULE;ORAL - 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Evonik, 1 Rochem International Inc, 2 SPI Pharma, 9 DKSH, 1 PMC Isochem, 1 Faran Shimi Pharmaceutical, 1 Gangwal Healthcare, 9 Nanjing Well Pharmaceutical, 4 ACG Worldwide, 7 Actylis, 1 Aeon Procare, 19 BASF, 1 Bioplus Life Sciences, 1 Clariant, 3 Corel Pharma Chem, 2 Finar, 7 Gangwal Chemicals, 2 Kerry, 3 Lonza Capsugel, 1 Lubrizol Life Science Health, 1 Microlex e.U, 3 Nanjing Bold Chemical, 2 Nomisma Healthcare, 2 Pluviaendo, 1 Qualicaps, 11 Roquette, 10 Seppic, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Sigachi Industries, 2 Valens Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

31 Solubilizers, 29 Topical, 19 Parenteral, 18 Film Formers & Plasticizers, 16 Thickeners and Stabilizers, 15 Emulsifying Agents, 14 Coating Systems & Additives, 10 Fillers, Diluents & Binders, 9 Surfactant & Foaming Agents, 8 Empty Capsules, 8 Controlled & Modified Release, 7 Taste Masking, 6 Granulation, 4 API Stability Enhancers, 4 Direct Compression, 4 Lubricants & Glidants, 3 Co-Processed Excipients, 3 Coloring Agents, 2 Rheology Modifiers, 2 Chewable & Orodispersible Aids, 1 Soft Gelatin, 1 Disintegrants & Superdisintegrants

31 Solubilizers
29 Topical
19 Parenteral
18 Film Formers & Plasticizers
16 Thickeners and Stabilizers
15 Emulsifying Agents
14 Coating Systems & Additives
10 Fillers, Diluents & Binders
9 Surfactant & Foaming Agents
8 Empty Capsules
8 Controlled & Modified Release
7 Taste Masking
6 Granulation
4 API Stability Enhancers
4 Direct Compression
4 Lubricants & Glidants
3 Co-Processed Excipients
3 Coloring Agents
2 Rheology Modifiers
2 Chewable & Orodispersible Aids
1 Soft Gelatin
1 Disintegrants & Superdisintegrants

DIGITAL CONTENT

2 Data Compilation #PharmaFlow, 161 News #PharmaBuzz

2 Data Compilation #PharmaFlow
161 News #PharmaBuzz

GLOBAL SALES INFORMATION

6 US Medicaid Prescriptions, 50 Regulatory FDF Prices, 13 Annual Reports

6 US Medicaid Prescriptions
50 Regulatory FDF Prices
13 Annual Reports

MARKET PLACE

27 APIs, 6 FDF Dossiers

27 APIs
6 FDF Dossiers

PATENTS & EXCLUSIVITIES

21 US Patents, 2 US Exclusivities, 60 Health Canada Patents

21 US Patents
2 US Exclusivities
60 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 2 USP, 1 JP, 3 Others

2 EDQM
2 USP
1 JP
3 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 1,306 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Name Reset all filters

2 All

01 2HARROW EYE

filter Product Reset all filters

2 All

01 2CYCLOSPORINE

filter Exclusivity Expiration Date Reset all filters

2 All

01 12026-05-30

02 12028-06-23

filter Exclusivity Code Reset all filters

2 All

01 1NP

02 1ODE-358

Product Main Page

HARROW EYE

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

CYCLOSPORINE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

ODE-358

Exclusivity Expiration Date

2028-06-23

Application Number

214965

Product Number

1

Exclusivity Details

01

HARROW EYE

Next-Gen Conjugates

Not Confirmed

HARROW EYE

U.S.A

Next-Gen Conjugates

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

CYCLOSPORINE

Exclusivity Code : ODE-358

Exclusivity Expiration Date : 2028-06-23

Application Number : 214965

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

HARROW EYE

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

CYCLOSPORINE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

NP

Exclusivity Expiration Date

2026-05-30

Application Number

217469

Product Number

1

Exclusivity Details

02

HARROW EYE

Next-Gen Conjugates

Not Confirmed

HARROW EYE

U.S.A

Next-Gen Conjugates

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

CYCLOSPORINE

Exclusivity Code : NP

Exclusivity Expiration Date : 2026-05-30

Application Number : 217469

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!